Amanda de Fraga Dias Selected Research

2,6- dichloro- 9- (1- (p- nitrobenzenesulfonyl)- 1,2,3,5- tetrahydro- 4,1- benzoxazepin- 3- yl)- 9H- purine

10/2021

Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amanda de Fraga Dias Research Topics

Disease

2	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 01/2020
1	Glioma (Gliomas) 01/2020
1	Neoplasms (Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

1	LipidsIBA 10/2021
1	2,6- dichloro- 9- (1- (p- nitrobenzenesulfonyl)- 1,2,3,5- tetrahydro- 4,1- benzoxazepin- 3- yl)- 9H- purineIBA 10/2021
1	NanocapsulesIBA 10/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	2-mercaptobenzimidazoleIBA 01/2020

Therapy/Procedure

1	Therapeutics 01/2020